We recently found that young cigarette smokers display cutaneous vascular dysfunction 20 relative to non-smokers, which is partially due to reduced nitric oxide (NO) synthase 21 (NOS)-dependent vasodilation. In this study, we tested the hypothesis that reducing 22 oxidative stress improves NO bioavailability, enhancing cutaneous vascular function in 23 young smokers. Ten healthy young male smokers, who had smoked for 6.3±0.7 years 24 with an average daily consumption of 9.1±0.7 cigarettes, were tested. Cutaneous 25 vascular conductance (CVC) during local heating to 42ºC at a rate of 0.1ºC/sec was 26 evaluated as laser-Doppler flux divided by mean arterial blood pressure and normalized 27 to maximal CVC, induced by local heating to 44ºC plus sodium nitroprusside 28 administration. We evaluated plateau CVC during local heating, which is known to be 29 highly dependent on NO, at four intradermal microdialysis sites: 1) Ringer's (control), 2) 30 10μM 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol), a superoxide dismutase 31 Tempol effect was exclusively NO-dependent. These data suggest that in young smokers, 37 reducing oxidative stress improves cutaneous thermal hyperemia to local heating by 38 enhancing NO production. 39 40
Introduction 42
Almost 6 million people die from tobacco use and exposure each year (53), and 43 the majority of tobacco-related deaths are due to cardiovascular disease (11) . Indeed, 44 chronic exposure to cigarette smoking changes the structure and function of human 45 conduit arteries (45). Oxidative stress is suspected to be a major contributor to chronic 46 cigarette smoking-induced vascular alterations, as reducing oxidative stress with 47
antioxidants (e.g., vitamin C) in smokers improves conduit artery vascular function, as 48 evaluated by non-invasive flow-mediated dilation (FMD) (41, 43, 50) or by intra-arterial 49 administration of the endothelium-dependent vasodilators, such as acetylcholine (ACh) 50 (17-19) and bradykinin (17). Furthermore, antioxidant-induced improvements in conduit 51 artery vascular function in smokers are not observed when administered in conjunction 52 with nitric oxide (NO) synthase (NOS) inhibition (31), suggesting that oxidative stress 53 impairs conduit artery function by reducing NO bioavailability. 54
In addition to human conduit artery function, chronic cigarette smoking impairs 55 function of the human microcirculation, such as the skin (9, 10, 14, 42) . Given that 56 microvascular dysfunction is a crucial step in the complications that lead to 57 cardiovascular disease (1, 34, 38) , exploring the mechanistic underpinnings of impaired 58 microvascular function in smokers is important; however, few investigators have studied 59 this issue. We recently reported that young smokers have an impaired cutaneous 60 vasodilatory response to administration of ACh compared with non-smokers, which was 61 partially due to attenuated . Given that oxidative stress 62 reduces NO bioavailability in the conduit arteries of smokers (31), reducing oxidative 63 stress may also improve NOS-dependent vasodilation in the cutaneous microcirculation 64 study to avoid any acute effects of cigarette smoking on skin blood flow regulation (9, 28, 88
52). 89
Instrumentation: Upon arrival at the laboratory, subjects voided their bladder and 90 body weight and height were measured. Subjects were placed in a semi-recumbent 91 position and instrumented with four microdialysis fibers (MD2000, Bioanalytical 92 Systems, West Lafayette, IN, USA) (30KDa cutoff, 10mm membrane) on the ventral side 93 of the forearm in the dermal layer of the skin. A 25-gauge needle was first inserted into 94 the unanesthetized skin using aseptic technique with at least 4.0cm between each site. 95
The entry and exit points were about ~2.5cm apart. The microdialysis fiber was then 96 threaded through the lumen of the needle, after which the needle was withdrawn leaving 97 the fiber in place. Microdialysis fibers were secured with tape. Lactated Ringer's 98 solution was perfused through each microdialysis fiber at a rate of 2.0µl/min (CMA 1025 99 microdialysis pump, CMA Microdialysis AB, Kista, Sweden) until the start of drug 100
infusions (see below). 101
Experimental protocol: Once the trauma caused by microdialysis fiber placement 102 had dissipated (~60-90min), the experimental protocol began. Microdialysis fibers were 103 randomly assigned to receive 1) Ringer's (control), 2) 10μM 4-hydroxy-2,2,6,6-104 tetramethylpiperidine-1-oxyl (Tempol, EMD Millipore Chemicals, Billerica, MA, USA) 105
St. Louis, MO, USA) to non-selectively inhibit NOS and thus NO production, and 4) 107 10μM Tempol plus 10 mM L-NNA. Drug concentrations were selected as the minimum 108 dose required for maximal effects, as reported in previous studies (36, 37 Instruments, Akron, OH). Figure 1 displays the CVC response to local heating, averaged 133 across all subjects, which was characterized as follows. Baseline CVC was determined 134 by taking an average CVC at least over 3min before heating. Upon initiation of local 135 heating, CVC rapidly increased and exhibited an initial peak. Then following a brief 136 nadir, CVC gradually increased and reached a stable plateau. The initial peak and nadir 137 CVC were determined by taking averaged CVC over 30sec, and the plateau and maximal 138 CVC were determined from averaged CVC over at least 2 min. We plateau, and maximal periods) for absolute (mV/MAP・100) and relative (%max) CVC. 147
We employed two-way ANOVA rather than one-way ANOVA to consider a potential 148 interaction between drug and phase of response. When a significant main effect or 149 interaction was detected, significant differences between paired variables across drug 150 sites were determined by Tukey's honestly significant difference post hoc test. 22, P=0.514) sites. Based on these data, we calculated the minimum sample sizes 179 required to produce a significant level of 0.05 with 80% power, which demonstrated we 180 would need 18 subjects for the difference in baseline CVC between the Ringer's and L-181 NNA sites to be significant, 28 subjects for the difference in initial peak CVC between 182 the Ringer's and Tempol sites to be significant, 28 subjects for the difference in absolute 183 maximal CVC between the Ringer's and Tempol sites to be significant, and 23 subjects 184 for the difference in absolute maximal CVC between the Ringer's and Tempol+L-NNA 185 sites to be significant. Relative to the Ringer's site, nadir CVC at the Tempol site was 186 higher, while that at the L-NNA and combination sites were lower ( Figure 1 with this, plateau CVC in the young smokers of the present study was attenuated 202 compared with that in the young non-smokers of previous studies in which the same 203 heating protocol was employed (Table 1) (3, 5, 16, 21, 33, 49, 54) . In the present study, 204
we found that Tempol significantly improved plateau CVC compared with the Ringer's 205 site (Figure 1 opening of calcium-activated potassium (K Ca ) channels has been reported in mesenteric 222 arterial smooth muscle of rats (55). However, these effects are unlikely to have occurred 223 in the present study focusing on human skin blood flow regulation in smokers as no independent Tempol effects were observed, as discussed below. 225
NOS pathway. An impaired NOS-dependent cutaneous vasodilation in smokers is 226
suggested by our previous study, which employed ACh administration (14), and by the 227 fact that, in the present study, NOS inhibition reduced plateau CVC during local heating 228 to a lesser extent than what has previously been reported in healthy young non-smokers 229 (19 vs. 33-72 %max) (3, 5, 13, 39, 40) . Given that oxidative stress generally reduces NO 230 bioavailability, it is plausible that in the present study, plateau CVC was improved with 231
Tempol administration through restoring NOS-dependent vasodilation. This notion is 232 strongly supported by our observation that there was no difference in plateau CVC 233 between the L-NNA and Tempol+L-NNA sites (Figure 1) . Also, the difference in Only male subjects were included in this study. Thus, our conclusions cannot be 261 applied to females. The female sex hormones may be cardio-protective against the 262 effects of chronic smoking, as reflected by the fact that carotid and femoral artery wall 263 thickness is greater (15) and conduit artery FMD is lower (6) in male smokers, but not in 264 female smokers compared with former or never smokers. Furthermore, the female sex 265 hormones enhance cutaneous thermal hyperemia to local heating (4, 7). Therefore, the 266 effects of chronic cigarette smoking on cutaneous thermal hyperemia may be different 267 between males and females and/or may be modulated by the levels of the female sex 268 hormones. Further studies are warranted to address these issues. 269
Absolute maximal CVC at the Tempol and Tempol+L-NNA sites tended to be 270 higher relative to that at the Ringer's site, though it was not significant due to limited 271 sample size. Reduced maximal cutaneous vasodilatory capacity has been reported in 272 young (14) and older (10) smokers relative to non-smoking counterparts. Our results 273 suggest this may be due to oxidative stress, but further studies are required to flush that 274 out. 275
For this study we chose not to study a subset of non-smokers, based on the 276 number of studies showing no benefit of antioxidant administration on vascular responses 277 in healthy, young non-smokers. Although doing so would have allowed us to make 278 comparisons between smokers and non-smokers, we decided to specifically focus this 279 study on investigating whether Tempol would improve cutaneous vascular function in 280 young smokers. 281
Perspectives. Microvascular dysfunction may be a crucial step in the 282 complications leading to cardiovascular disease, and can be detected in the early stages of 283 disease progression in the cutaneous circulation (24, 27, 38 ). The present study shows 284 that impaired cutaneous microvascular function in young smokers is caused by oxidative 285 stress in a similar fashion as is observed in aging (25). As such, chronic cigarette 286 smoking has been suggested to cause a premature aging effect. Based on our results, we 287 speculate that, reducing oxidative stress in young smokers may potentially reduce the 288 premature aging effect of chronic cigarette smoking on microvascular function, which in 289 turn, may prevent or delay smoking-related cardiovascular disease and mortality. 290
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